Patent · US Active

Compounds and methods for kinase modulation, and indications therefor

US7872018B2 · kind B2 · utility

47Cited by
72References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2007
Grant dateJan 18, 2011
Priority date
Expiry dateJul 19, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.